Sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial-Reference-Cited by-同舟云学术

Sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial

Published:2010-10-15 Issue:4 Volume:213 Page:809-815
ISSN:0033-3158
Container-title:Psychopharmacology
language:en
Short-container-title:Psychopharmacology

Author:

Akhondzadeh Shahin,Ghayyoumi Raofeh,Rezaei Farzin,Salehi Bahman,Modabbernia Amir-Hossein,Maroufi Azad,Esfandiari Gholam-Reza,Naderi Mehrangiz,Ghebleh Fariba,Tabrizi Mina,Rezazadeh Shams-Ali

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s00213-010-2044-z.pdf

Reference28 articles.

1. Abbasi SH, Behpournia H, Ghoreshi A, Salehi B, Raznahan M, Rezazadeh SA, Rezaei F, Akhondzadeh S (2010) The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: a double-blind randomized placebo-controlled trial. Schizophr Res 116:101–106

2. Akhondzadeh S (1998) The glutamate hypothesis of schizophrenia. J Clin Pharm Ther 23:243–246

3. Akhondzadeh S (2001) The 5-HT hypothesis of schizophrenia. IDrugs 4:295–300

4. Akhondzadeh S (2006) Pharmacotherapy of schizophrenia: the past, present and future. Curr Drug Ther 1:1–7

5. Akhondzadeh S, Mohammadi MR, Amini-Nooshabadi H, Davari Ashtiani R (1999) Cyproheptadine in treatment of chronic schizophrenia: a double-blind, placebo-controlled study. J Clin Pharm Ther 24:49–42

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effectiveness of Augmenting Modafinil to Risperidone or Olanzapine for Treating Negative Symptoms in Schizophrenic Patients: A Randomized Controlled Trail;Jundishapur Journal of Chronic Disease Care;2024-03-13

2. Mirtazapine in schizophrenia – an undeservedly overlooked option?;International Clinical Psychopharmacology;2022-03-31

3. Cilostazol as an adjunctive treatment in major depressive disorder: a pilot randomized, double-blind, and placebo-controlled clinical trial;Psychopharmacology;2022-01-24

4. Phosphodiesterase-5 inhibitors: Shedding new light on the darkness of depression?;Journal of Affective Disorders;2020-03

5. Therapeutic targeting of 3′,5′-cyclic nucleotide phosphodiesterases: inhibition and beyond;Nature Reviews Drug Discovery;2019-08-06